Deplera (rituximab biosimilar) / Generium - LARVOL DELTA

Steroid-Sparing Rituximab in Polymyalgia Rheumatica (RheumNow) - "BRIDGE-PMR proof-of-concept trial assessed the efficacy of rituximab (RTX) in patients with polymyalgia rheumatica (PMR) and showed that a single 1000 mg dose of lead to a significant number of glucocorticoid-free remissions after 1 year....A single dose of rituximab (1000 mg) lead to a significantly higher rate of glucocorticoid-free remission at 1 year, suggesting the feasibility of this approach and need for further study."

Online posting